Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis
NCT00357773 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2006-07-27
Summary
To demonstrate the efficacy of T1225 1.5% eye drops, in comparison to reference product, for the treatment of purulent bacterial conjunctivitis, and to assess the safety
Conditions
- Conjunctivitis, Bacterial
Interventions
- DRUG
-
Azithromycin (T1225)
Sponsors & Collaborators
-
Laboratoires Thea
lead INDUSTRY
Principal Investigators
-
Isabelle COCHEREAU, Professor · CHU d'Angers, France
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Day
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-05-31
- Completion
- 2005-06-30
More Related Trials
-
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
NCT00105469 ·Status: COMPLETED ·Phase: PHASE3
-
Zylet vs TobraDex in Blepharokeratoconjunctivitis
NCT00447577 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
NCT01721694 ·Status: WITHDRAWN ·Phase: PHASE3
-
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
NCT01028027 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
NCT01344083 ·Status: COMPLETED ·Phase: PHASE2
-
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636)
NCT01269658 ·Status: TERMINATED ·Phase: PHASE2
-
A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)
NCT01220258 ·Status: TERMINATED ·Phase: PHASE2
-
Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis
NCT01227915 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis
NCT00705159 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis
NCT01178762 ·Status: COMPLETED ·Phase: NA
-
Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy
NCT01379196 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis
NCT01102244 ·Status: COMPLETED ·Phase: PHASE3
-
To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension
NCT03975374 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis
NCT01560962 ·Status: TERMINATED ·Phase: NA
-
Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis
NCT00754949 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparing Efficacy of Tea Tree Oil Versus Topical Azithromycin in Treating Dry Eye
NCT06921525 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis
NCT02432807 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis
NCT00578955 ·Status: COMPLETED ·Phase: PHASE3
-
Systemic Pharmacokinetics of BOL-303224-A
NCT00407589 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis
NCT01238783 ·Status: WITHDRAWN ·Phase: PHASE2
-
TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
NCT00576251 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period
NCT00892970 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)
NCT00894530 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults
NCT06616922 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
NCT01456780 ·Status: COMPLETED ·Phase: PHASE4